NCT01742234

Brief Summary

An organ transplant is frequently the best option and, in some cases, the only option to save the lives of transplant recipients. Receiving an organ from a living donor eliminates the need to wait for a deceased donor, an option that many transplant recipients do not survive. However, donating an organ presents health concerns to the donor as well. This study will use surveys to evaluate the understanding of risk and psychological pressure that living organ donors felt when making the decision to donate. It will also compare participants' answers across geographic, racial and socio-economic backgrounds.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
624

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2008

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

November 28, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 5, 2012

Completed
Last Updated

March 27, 2017

Status Verified

March 1, 2017

Enrollment Period

2.3 years

First QC Date

November 28, 2012

Last Update Submit

March 23, 2017

Conditions

Outcome Measures

Primary Outcomes (3)

  • Questionnaire Score 1

    Feelings of pressure to donate an organ on a 4-point scale e.g.; "1: No pressure" to "4: A lot of pressure."

    Change from 1 week prior to donation and 3 months after donation

  • Questionnaire Score 2

    Understanding of the donor screening process on a 4-point scale e.g.; "1: No understanding" to "4: Full understanding."

    Change from 1 week prior to donation and 3 months after donation

  • Questionnaire Score 3

    Understanding of medical and psychosocial consequences of organ donation on a 4-point scale e.g.; "1: No understanding" to "4: Full understanding."

    Change from 1 week prior to donation and 3 months after donation

Secondary Outcomes (4)

  • Questionnaire Score Secondary Endpoint 1

    Change from 1 week prior to donation and 3 months after donation

  • Questionnaire Score Secondary Endpoint 2

    Change from 1 week prior to donation and 3 months after donation

  • Questionnaire Score Secondary Endpoint 3

    Change from 1 week prior to donation and 3 months after donation

  • Questionnaire Score Secondary Endpoint 4

    Change from 1 week prior to donation and 3 months after donation

Study Arms (2)

Kidney Donors

People who will donate a kidney at the University of Minnesota, Mayo Clinic, or University of Alabama

Procedure: Organ Donation

Lung Donors

People who will donate a lung at the Washington University School of Medicine or the University of Southern California

Procedure: Organ Donation

Interventions

People in this study will donate either a lung or kidney

Kidney DonorsLung Donors

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

People who will be donating at kidney at the University of Minnesota, Mayo Clinic, or University of Alabama or people who will be donating a lung at University of Washington Medical School or the University of Southern California

You may qualify if:

  • Living donor of a kidney or lung

You may not qualify if:

  • Unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Valapour M, Kahn JP, Bailey RF, Matas AJ. Assessing elements of informed consent among living donors. Clin Transplant. 2011 Mar-Apr;25(2):185-90. doi: 10.1111/j.1399-0012.2010.01374.x. Epub 2010 Dec 16.

Related Links

MeSH Terms

Interventions

Tissue and Organ Procurement

Intervention Hierarchy (Ancestors)

Health ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Maryam Valapour, MD

    University of Minnesota, Center for Bioethics

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2012

First Posted

December 5, 2012

Study Start

August 1, 2008

Primary Completion

November 1, 2010

Study Completion

November 1, 2010

Last Updated

March 27, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will share

Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.

Available IPD Datasets

Individual Participant Data Set (SDY292)Access
Study Protocol (SDY292)Access